| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Departments of Biochemistry and Molecular Genetics and Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado 80262
E2F transcriptional activity controls the expression of many of the genes required for G1 to S phase progression. E2F1, one member of the E2F family, plays an important role in the induction of apoptosis. We have examined the role of the E2F1 transcription factor in apoptosis during T-cell maturation in the thymus. We show that E2F1 is required for the apoptosis of autoimmune immature T cells during thymic negative selection in vivo. This T-cell receptor-mediated apoptosis coincides with the E2F1-dependent increase of p19-ARF mRNA and p53 protein levels. In contrast, E2F1 is not required for the induction of apoptosis by glucocorticoids or DNA damage. These results demonstrate a specific role for E2F1, which triggers a pathway leading to ARF and p53 induction, in a physiological apoptosis pathway that is uncoupled from a normal proliferative event.
This article has been cited by other articles:
![]() |
H. Ebelt, Y. Zhang, A. Kampke, J. Xu, A. Schlitt, M. Buerke, U. Muller-Werdan, K. Werdan, and T. Braun E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo Cardiovasc Res, November 1, 2008; 80(2): 219 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Panchanathan, H. Xin, and D. Choubey Disruption of Mutually Negative Regulatory Feedback Loop between Interferon-Inducible p202 Protein and the E2F Family of Transcription Factors in Lupus-Prone Mice J. Immunol., May 1, 2008; 180(9): 5927 - 5934. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, D. P. Yin, Y.-X. Liu, R. Baer, and Y. Yin Dual Specificity Phosphatase 1/CL100 Is a Direct Transcriptional Target of E2F-1 in the Apoptotic Response to Oxidative Stress Cancer Res., July 15, 2007; 67(14): 6737 - 6744. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, W. H. Shen, Y. J. Jin, P. W. Brandt-Rauf, and Y. Yin A Molecular Link between E2F-1 and the MAPK Cascade J. Biol. Chem., June 22, 2007; 282(25): 18521 - 18531. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qiao, L. Di Stefano, C. Tian, Y.-Y. Li, Y.-H. Yin, X.-P. Qian, X.-W. Pang, Y. Li, M. A. McNutt, K. Helin, et al. Human TFDP3, a Novel DP Protein, Inhibits DNA Binding and Transactivation by E2F J. Biol. Chem., January 5, 2007; 282(1): 454 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Novakovic, J. M. Stempak, K.-J. Sohn, and Y.-I. Kim Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells Carcinogenesis, May 1, 2006; 27(5): 916 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tan, L. Zhuang, X. Jiang, K. K. Yang, K. M. Karuturi, and Q. Yu Apoptosis Signal-regulating Kinase 1 Is a Direct Target of E2F1 and Contributes to Histone Deacetylase Inhibitorinduced Apoptosis through Positive Feedback Regulation of E2F1 Apoptotic Activity J. Biol. Chem., April 14, 2006; 281(15): 10508 - 10515. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xie, P. Jiang, L. Miao, Y. Zhao, Z. Zhimin, L. Qing, W.-g. Zhu, and M. Wu Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1. Nucleic Acids Res., January 1, 2006; 34(7): 2046 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, J. Tan, L. Zhuang, X. Jiang, E. T. Liu, and Q. Yu Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim PNAS, November 1, 2005; 102(44): 16090 - 16095. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, J. Stanelle, C. Leurs, H. Hanenberg, and B. M. Putzer Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library Nucleic Acids Res., May 16, 2005; 33(9): 2813 - 2821. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ebelt, N. Hufnagel, P. Neuhaus, H. Neuhaus, P. Gajawada, A. Simm, U. Muller-Werdan, K. Werdan, and T. Braun Divergent Siblings: E2F2 and E2F4 but not E2F1 and E2F3 Induce DNA Synthesis in Cardiomyocytes Without Activation of Apoptosis Circ. Res., March 18, 2005; 96(5): 509 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Salam, K. Matin, N. Matsumoto, Y. Tsuha, N. Hanada, and H. Senpuku E2f1 Mutation Induces Early Onset of Diabetes and Sjogren's Syndrome in Nonobese Diabetic Mice J. Immunol., October 15, 2004; 173(8): 4908 - 4918. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ianari, R. Gallo, M. Palma, E. Alesse, and A. Gulino Specific Role for p300/CREB-binding Protein-associated Factor Activity in E2F1 Stabilization in Response to DNA Damage J. Biol. Chem., July 16, 2004; 279(29): 30830 - 30835. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cao, Y. Xia, M. Azadniv, and I. N. Crispe The E2F-1 Transcription Factor Promotes Caspase-8 and Bid Expression, and Enhances Fas Signaling in T Cells J. Immunol., July 15, 2004; 173(2): 1111 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yi, A. Shepard, F. Kittrell, B. Mulac-Jericevic, D. Medina, and T. K. Said p19ARF Determines the Balance between Normal Cell Proliferation Rate and Apoptosis during Mammary Gland Development Mol. Biol. Cell, May 1, 2004; 15(5): 2302 - 2311. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Liu, Y. Luo, F.-T. Lin, and W.-C. Lin TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival Genes & Dev., March 15, 2004; 18(6): 673 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Scheijen, M. Bronk, T. van der Meer, D. De Jong, and R. Bernards High Incidence of Thymic Epithelial Tumors in E2F2 Transgenic Mice J. Biol. Chem., March 12, 2004; 279(11): 10476 - 10483. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Verschuren, J. G. Hodgson, J. W. Gray, S. Kogan, N. Jones, and G. I. Evan The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis Cancer Res., January 15, 2004; 64(2): 581 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Hallstrom and J. R. Nevins Specificity in the activation and control of transcription factor E2F-dependent apoptosis PNAS, September 16, 2003; 100(19): 10848 - 10853. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ziebold, E. Y. Lee, R. T. Bronson, and J. A. Lees E2F3 Loss Has Opposing Effects on Different pRB-Deficient Tumors, Resulting in Suppression of Pituitary Tumors but Metastasis of Medullary Thyroid Carcinomas Mol. Cell. Biol., September 15, 2003; 23(18): 6542 - 6552. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. DeRyckere, D. L. Mann, and J. DeGregori Characterization of Transcriptional Regulation During Negative Selection In Vivo J. Immunol., July 15, 2003; 171(2): 802 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. X. Li, J. W. Zhu, C. J. Hogan, and J. DeGregori Defective Gene Expression, S Phase Progression, and Maturation during Hematopoiesis in E2F1/E2F2 Mutant Mice Mol. Cell. Biol., May 15, 2003; 23(10): 3607 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gonzalez, A. Orlofsky, and M. B. Prystowsky A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells Blood, April 1, 2003; 101(7): 2679 - 2685. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Cloud, C. Rogers, T. L. Reza, U. Ziebold, J. R. Stone, M. H. Picard, A. M. Caron, R. T. Bronson, and J. A. Lees Mutant Mouse Models Reveal the Relative Roles of E2F1 and E2F3 In Vivo Mol. Cell. Biol., April 15, 2002; 22(8): 2663 - 2672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Zhu, S. J. Field, L. Gore, M. Thompson, H. Yang, Y. Fujiwara, R. D. Cardiff, M. Greenberg, S. H. Orkin, and J. DeGregori E2F1 and E2F2 Determine Thresholds for Antigen-Induced T-Cell Proliferation and Suppress Tumorigenesis Mol. Cell. Biol., December 15, 2001; 21(24): 8547 - 8564. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Nevins The Rb/E2F pathway and cancer Hum. Mol. Genet., April 1, 2001; 10(7): 699 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Harbour and D. C. Dean The Rb/E2F pathway: expanding roles and emerging paradigms Genes & Dev., October 1, 2000; 14(19): 2393 - 2409. [Full Text] |
||||
![]() |
A. Groth, J. D. Weber, B. M. Willumsen, C. J. Sherr, and M. F. Roussel Oncogenic Ras Induces p19ARF and Growth Arrest in Mouse Embryo Fibroblasts Lacking p21Cip1 and p27Kip1 without Activating Cyclin D-dependent Kinases J. Biol. Chem., August 25, 2000; 275(35): 27473 - 27480. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |